Glycoprotein Matrix-Bound Iron Improves Iron Absorption

Palo Alto (17 mi)

Age: 18 - 65

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: N/A

Waitlist Available

Sponsor: University of Mary Hardin-Baylor

No Placebo Group

Trial Summary

What is the purpose of this trial?A double-blind, randomized crossover study was conducted that evaluated absorption kinetics of 3 forms of dietary supplement iron by measuring iron levels in the blood after acute ingestion.

Eligibility Criteria

Treatment Details

3Treatment groups

Experimental Treatment

Group I: glycoprotein matrix ironExperimental Treatment1 Intervention

Acute glycoprotein matrix iron was ingested to assess blood appearance levels from pre and at 30-, 60-, 90-, 120-, 180-, 240-, 300-, 360-, 420-, and 480-minutes post-ingestion.

Group II: ferrous fumarate ironExperimental Treatment1 Intervention

Acute ferrous fumarate iron was ingested to assess blood appearance levels from pre and at 30-, 60-, 90-, 120-, 180-, 240-, 300-, 360-, 420-, and 480-minutes post-ingestion.

Group III: ferrous bisglycinate chelate ironExperimental Treatment1 Intervention

Acute ferrous bisglycinate chelate iron was ingested to assess blood appearance levels from pre and at 30-, 60-, 90-, 120-, 180-, 240-, 300-, 360-, 420-, and 480-minutes post-ingestion.